Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?

Acta Obstetricia et Gynecologica Scandinavica

Volumn 99, Issue 4, 2020, Pages 439-442

  Liang, Huan ^a   Acharya, Ganesh ^b,c  

^a OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; BETAMETHASONE; CHLOROQUINE; CORTICOSTEROID; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; REMDESIVIR; COVID-19; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

ADVERSE OUTCOME; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BREAST MILK; CESAREAN SECTION; COMORBIDITY; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; CORTICOSTEROID THERAPY; COUGHING; DYSPNEA; ELECTROLYTE BALANCE; FATIGUE; FEVER; HUMAN; INCUBATION TIME; INFECTION PREVENTION; MYALGIA; NEWBORN CARE; NUTRITIONAL SUPPORT; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; REST; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOCIAL HYGIENE; SORE THROAT; VAGINAL DELIVERY; VIRAL CLEARANCE; BETACORONAVIRUS; DISEASE PREDISPOSITION; EPIDEMIC; FEMALE; PATIENT CARE PLANNING; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; VIROLOGY; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; PATIENT CARE PLANNING; PNEUMONIA, VIRAL; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 85081609193     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.13836     Document Type: Article

References (15)

1. Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. https://doi.org/10.1016/S0140-6736(20)30154-9
2. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001316
3. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2001468
4. Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
5. Wu Z, McGoogan JM. Characteristics of and Important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. https://doi.org/10.1001/jama.2020.2648
6. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020;323(8):709. https://doi.org/10.1001/jama.2020.1097
7. Zhang M. Protecting healthcare workers in China during the coronavirus outbreak. BMJ. 2020. https://blogs.bmj.com/bmj/2020/02/14/min-zhang-protecting-healthcare-workers-china-coronavirus-outbreak/. Accessed Feb 28, 2020
8. World Health Organization (WHO). Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed Feb 28, 2020
9. Centers for Disease Control and Prevention (CDC). Interim Considerations for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Inpatient Obstetric Healthcare Settings. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html. Accessed Feb 28, 2020
10. Maternal and Fetal Experts Committee, Chinese Physician Society of Obstetrics and Gynecology, Chinese Medical Doctor Association, Obstetric Subgroup, et al. Proposed management of 2019-novel coronavirus infection during pregnancy and puerperium. Chin J Perinat Med. 2020;23(02):73-79. https://doi.org/10.3760/cma.j.issn.1007-9408.2020.02.001
11. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30360-3
12. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60. https://doi.org/10.21037/tp.2020.02.06
13. Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020. https://doi.org/10.1148/radiol.2020200642
14. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020. https://doi.org/10.1038/s41422-020-0282-0
15. Qia J. What are the risks of COVID-19 infection in pregnant women? Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30365-2